High homogeneity of mage, bage, gage, tyrosinase and Melan-A/Mart-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen-specific vaccination strategies

International Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 200-204

  Dalerba, Piero ^a   Ricci, Axel ^a   Russo, Vincenzo ^a   Rigatti, Donata ^a   Nicotra, Maria Rita ^b   Mottolese, Marcella ^c   Bordicnon, Claudio ^a   Natali, Pier Giorgio ^c   Traversari, Catia ^a,d  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b CNR   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; VACCINE;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; FEMALE; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION;

ANTIGENS, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS;

EID: 0031806535     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980717)77:2<200::AID-IJC5>3.0.CO;2-U     Document Type: Article

References (22)

1. AJCC, Manual for staging of cancer, pp. 143-148, J.B. Lippincott, Philadelphia (1992).
2. ALBINO, A.P. and FOUNTAIN, J.W., Molecular genetics of human malignant melanoma. Cancer Treat. Res., 65, 201-255 (1993).
3. ANICHINI, A., FOSSATI, G. and PARMIANI, G., Heterogeneity of clones from human metastatic melanoma detected by autologous cytotoxic-T-lymphocyte clones. J. exp. Med., 163, 215-220 (1986).
4. BOËL, P., WILDMANN, C., SENSI, M.L., BRASSEUR, R., RENAULD, J.C., COULIE, P., BOON, T. and VAN DER BRUGGEN, P., BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175 (1995).
5. BOON, T. and VAN DER BRUGGEN, P., Human tumor antigens recognized by T lymphocytes. J. exp. Med., 183, 725-729 (1996).
6. BRASSEUR, F. and 29 OTHERS. Expression of MAGE genes in primary and metastatic melanoma. Int. J. Cancer, 63, 375-380 (1995).
7. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WÖLFEL, C., DE PLAEN, E., LETHÉ, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
8. CHEN, Y.T., STOCKERT, E., JUNGBLUTH, A., TSANG, S., COPLAN, K.A., SCANLAN, M.J. and OLD, L.J., Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc. nat. Acad. Sci. (Wash.), 93, 5915-5919 (1996).
9. CHEN, Y.T., STOCKERT, E., TSANG, S., COPLAN, K.A. and OLD, L.J., Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. nat. Acad. Sci. (Wash.), 92, 8125-8129 (1995).
10. COULIE, P.O., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.P., RENAULD, J.C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
11. FERRONE, S. and MARINCOLA, F., Loss of HLA-class-I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16, 487-494 (1995).
12. JÄGER, E., RINGHOFFER, M., ALTMANNSBERGER, M., ARAND, M., KARBACH, J., JÄGER, D., OESCH, F. and KNUTH, A., Immunoselection in vivo: independent loss of MHC-class-I and melanocyte differentiation-antigen expression in metastatic melanoma. Int. J. Cancer, 71, 142-147 (1997).
13. LEHMANN, F., MARCHAND, M., HAINAUT, P., POUILLART, P., SASTRE, X., IKEDA, H., BOON, T. and COULIE, P., Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Europ. J. Immunol., 25, 340-347 (1995).
14. MARCHAND, M. and 20 OTHERS, Tumor-regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
15. MARINCOLA, F.M., HIJAZI, Y.M., FETSCH, P., SALGALLER, M.L., RIVOLTINI, L., CORMIER, J., SIMONIS, T.B., DURAY, P.H., HERLYN, M., KAWAKAMI, Y. and ROSENBERG, S.A., Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic-melanoma cell lines and in situ lesions. J. Immunother. Emphasis Tumor Immunol., 19, 192-205 (1996).
16. MORTON, D.L. and BARTH, A., Vaccine therapy for malignant melanoma. CA-Cancer J. Clin., 46, 225-244 (1996).
17. NATALI, P.G., CAVALIERE, R., BIGOTTI, A., NICOTRA, M.R., RUSSO, C., NG, A.K., GIACOMINI, P. and FERRONE, S., Antigenic heterogeneity of surgically removed primary and autologous metastatic lesions. J. Immunol., 130, 1462-1466 (1983).
18. REDONDO, M., CONCHA, A., OLDIVIELA, R., CUETO, A., GONZALEZ, A., GARRIDO, F. and RUIZ-CABELLO, F., Expression of HLA-class-I and -II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res., 51, 4948-4954 (1993).
19. RUNGER, T.M., KLEIN, C.E., BECKER, J.C. and BROCKER, E.B., The role of genetic instability, adhesion, cell motility and immune escape mechanisms in melanoma progression. Curr. Opin. Oncol., 6, 188-196 (1994).
20. RUSSO, V., TRAVERSARI, C., VERRECCHIA, A., MOTTOLESE, M., NATALI, P.G. and BORDIGNON, C., Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor-antigen-specific immunotherapy. Int. J. Cancer, 64, 1-6 (1995).
21. VAN DEN EYNDE, B., PEETERS, O., DE BACKER, O., GAUGLER, B., LUCAS, S. and BOON, T., A new family of genes coding for an antigen recognized by autologous cytolitic T lymphocytes on a human melanoma. J. exp. Med., 182, 689-698 (1995).
22. VAN DUINEN, S.G., RUITER, D.J., BROECKER, E.B., VAN DER VELDE, E.A., SORG, C., WELVAART, K. and FERRONE, S., Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res., 48, 1019-1025 (1988).